A detailed history of Bryant Woods Investment Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bryant Woods Investment Advisors, LLC holds 1,547 shares of ABBV stock, worth $282,992. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,547
Previous 1,522 1.64%
Holding current value
$282,992
Previous $261,000 16.86%
% of portfolio
0.16%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $4,096 - $4,983
25 Added 1.64%
1,547 $305,000
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $3,405 - $3,976
22 Added 1.47%
1,522 $261,000
Q1 2024

May 02, 2024

SELL
$159.82 - $182.1 $20,776 - $23,673
-130 Reduced 7.98%
1,500 $273,000
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $14,860 - $16,736
108 Added 7.1%
1,630 $252,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $203,323 - $235,377
1,522 New
1,522 $226,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bryant Woods Investment Advisors, LLC Portfolio

Follow Bryant Woods Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryant Woods Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bryant Woods Investment Advisors, LLC with notifications on news.